HK Stock Market Move | AVICHINA (02357) rose over 5% in late trading; the Z-10ME attack helicopter recently made its debut at the Africa Aerospace and Defence Expo.
AVICHINA (02357) rose over 5% in late trading. As of press time, it was up 4.87% at HK$3.12, with a turnover of HK$122 million.
AVICHINA (02357) rose over 5% in late trading. As of press time, it was up 4.87% at HK$3.12, with a turnover of HK$122 million.
On the news front, on September 16, the 13th Africa Aerospace and Defence Expo (AAD2026) officially opened at Waterkloof Air Force Base in Pretoria, South Africa, where AVICOPTER PLC's Z-10ME, Z-11, AC332 and other models were showcased. EB SECURITIES pointed out that AVICOPTER PLC is the overall listing platform for the helicopter business under the Aviation Industry Corporation of China, and is also an important enterprise in China's low-altitude economy, with a complete industrial chain foundation and deep alignment with the national low-altitude economy strategy.
Public information shows that AVICHINA is the overseas capital operation platform under the Aviation Industry Corporation of China, having built a full industrial chain system covering complete aircraft, supporting systems and aviation engineering services. It is reported that AVICHINA's subsidiaries mainly include: AVICOPTER PLC (approximately 53.6% stake), Jiangxi Hongdu Aviation Industry (approximately 43.8% stake), Jonhon Optronic Technology (approximately 36.7% stake), AVIC Airborne Systems (approximately 16.5% stake), etc.
Related Articles

Nanjing King-Friend Biochemical Pharmaceutical (603707.SH) subsidiary's product Adalimumab Injection receives U.S. FDA approval.

Shandong Hualu-Hengsheng Chemical (600426.SH): Relevant production facilities under shutdown for maintenance have resumed operation.

CLSA: China's semiconductor demand momentum continues; wafer foundries continue to expand capacity.
Nanjing King-Friend Biochemical Pharmaceutical (603707.SH) subsidiary's product Adalimumab Injection receives U.S. FDA approval.

Shandong Hualu-Hengsheng Chemical (600426.SH): Relevant production facilities under shutdown for maintenance have resumed operation.

CLSA: China's semiconductor demand momentum continues; wafer foundries continue to expand capacity.






